Decanoic Acid

Decanoic Acid

SCHEMBL4930808

CCCCCCCCCC(=O)O.O=C(O)CCCCCCCC(O)CO

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 3/20 0.82
▸ FFAR1 O14842 3/20 0.82
▸ GPR84 Q9NQS5 11/20 0.63
▸ PPARG P37231 7/20 0.63
▸ PPARD Q03181 7/20 0.63
▸ PPARA Q07869 7/20 0.63
▸ HDAC11 Q96DB2 5/20 0.63
▸ TSHR P16473 4/20 0.63
▸ PTPN1 P18031 3/20 0.63
▸ ALDH1A1 P00352 2/20 0.63
▸ TLR2 O60603 2/20 0.63
▸ TDP1 Q9NUW8 2/20 0.63
▸ FABP4 P15090 2/20 0.63
▸ SLC22A6 Q4U2R8 1/20 0.63
▸ SLC22A8 Q8TCC7 1/20 0.63
▸ MEN1 O00255 1/20 0.63
▸ ESR1 P03372 1/20 0.63
▸ ALOX15 P16050 1/20 0.63
▸ PDE4A P27815 1/20 0.63
▸ KMT2A Q03164 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Octanoic Acid SCHEMBL30573275 1.00 FFAR4 (0.82) FFAR4FFAR1GPR84PPARGPPARD
Octanoic Acid SCHEMBL6416694 1.00 FFAR4 (0.82) FFAR4FFAR1GPR84PPARGPPARD
Decanoic Acid SCHEMBL28170620 1.00 FFAR4 (0.82) FFAR4FFAR1GPR84PPARGPPARD
Behenic Acid SCHEMBL20786761 1.00 FFAR4 (0.82) FFAR4FFAR1GPR84PPARGPPARD
Adipic Acid SCHEMBL10823133 1.00 FFAR4 (0.82) FFAR4FFAR1GPR84PPARGPPARD
Decanoic Acid SCHEMBL30568110 0.96 FFAR4 (0.76) FFAR4FFAR1GPR84PPARGPPARD
Octanoic Acid SCHEMBL28947661 0.96 FFAR4 (0.76) FFAR4FFAR1GPR84PPARGPPARD
Stearic Acid SCHEMBL28809913 0.96 FFAR4 (0.76) FFAR4FFAR1GPR84PPARGPPARD
Sebacic Acid SCHEMBL20164085 0.95 FFAR4 (0.74) FFAR4FFAR1GPR84PPARGPPARD
Glycerin SCHEMBL2142294 0.95 FFAR4 (0.86) FFAR4FFAR1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249147-A1 Emulsion-Stabilized Preparation TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-09 — — US claimed
EP-1728504-A1 EMULSION STABILIZER Takeda Pharmaceutical Company Limited (JP) 2006-12-06 — — EP claimed
EP-1728504-B1 EMULSION STABILIZER TAKEDA PHARMACEUTICAL (JP) 2013-07-31 — — EP disclosed
US-20080249147-A1 Emulsion-Stabilized Preparation TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-09 — — US disclosed
EP-1728504-A1 EMULSION STABILIZER Takeda Pharmaceutical Company Limited (JP) 2006-12-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249147-A1 Emulsion-Stabilized Preparation LIPA, MGLL, SI FFAR4 31/4885FFAR1 29/4885GPR84 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback